基于术前多参数磁共振成像的胶质母细胞瘤PTEN突变影像基因组学分析
研究从每例患者提取862个影像组学特征,在训练集(n=69,来自癌症基因组图谱)和验证集(n=40,来自中国脑胶质瘤基因组图谱)中构建支持向量机模型预测胶质母细胞瘤PTEN突变状态,模型AUC分别为0.925和0.787,优于单个特征,影像基因组学分析显示影像组学特征可描述PTEN相关生物学过程。
要点
- 术前多参数MRI影像组学特征可用于预测胶质母细胞瘤PTEN突变状态。
- 机器学习模型在训练集和验证集的AUC分别为0.925和0.787。
- 所选6个特征中2个来自增强图像、4个来自T2加权图像。
核心结论
- 基于术前MRI的影像组学特征可预测胶质母细胞瘤患者PTEN突变状态,提供一种新的无创影像生物标志物。
研究设计与样本
- 回顾性研究,训练集n=69来自癌症基因组图谱,验证集n=40来自中国脑胶质瘤基因组图谱,每例提取862个影像组学特征,采用最小冗余最大相关算法筛选特征并用支持向量机分类器建模,以ROC曲线下面积评估性能。
诊断标准与关键数值
- 最小冗余最大相关算法筛选出6个特征(2个来自增强图像、4个来自T2加权图像),支持向量机模型预测PTEN突变状态的AUC在训练集为0.925、在验证集为0.787。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: PTEN mutation status is a pivotal biomarker for glioblastoma. This study aimed to establish a radiomic signature to predict PTEN mutation status in patients with glioblastoma, and to investigate the genetic background behind this radiomic signature.
METHODS: In this study, a total of 862 radiomic features were extracted from each patient. The training (n = 69) and validation (n = 40) sets were retrospectively collected from the Cancer Genome Atlas and the Chinese Glioma Genome Atlas, respectively. The minimum redundancy maximum relevance (mRMR) algorithm was used to select the best predictive features of PTEN status. A machine learning model was then built with the selected features using a support vector machine classifier. The predictive performance of each selected feature and the complete model were evaluated via the area under the curve from receiver operating characteristic analysis in both the training and validation sets. The genetic background underlying the radiomic signature was determined using radiogenomic analysis.
RESULTS: Six features were selected using the mRMR algorithm, including two features derived from contrast-enhanced images and four features derived from T2-weighted images. The predictive performance of the machine learning model for the training and validation sets were 0.925 and 0.787, respectively, which were better than the individual features. Radiogenomics analysis revealed that the PTEN-associated biological processes could be described using the radiomic signature.
CONCLUSION: These results show that radiomic features derived from preoperative MRI can predict PTEN mutation status in glioblastoma patients, thus providing a novel noninvasive imaging biomarker.
引用
- Li Y, Liang Y, Sun Z, et al. Radiogenomic analysis of PTEN mutation in glioblastoma using preoperative multi-parametric magnetic resonance imaging. Neuroradiology. 2019. PMID: 31218383. doi:10.1007/s00234-019-02244-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。